Weight management counselling among community pharmacists: a scoping review

Rosenthal, Meagen; Ward, Lori M.; Teng, Jing; Haines, Seena L.

doi:10.1111/ijpp.12453

Cited by 13 publications

(11 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been shown that pharmacist involvement in the dispensing of naloxone had significant reductions in fatal opioid overdoses as opposed to just improving access [56]. Other wellness and prevention services include weight management, fluoride treatments, falls prevention, pharmacogenomics, sleep assessment, drug take back, nutraceuticals, and bioidentical hormone replacement [57,58,59,60,61,62]. Lastly, community-based pharmacist practitioners are involved in providing Medicare Annual Wellness Visits in physician offices [63].…”

Section: Resultsmentioning

confidence: 99%

Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States

et al. 2019

View full text Add to dashboard Cite

Community-based pharmacy practice is evolving from a focus on product preparation and dispensing to becoming a health care destination within the four walls of the traditional community-based pharmacy. Furthermore, community-based pharmacy practice is expanding beyond the four walls of the traditional community-based pharmacy to provide care to patients where they need it. Pharmacists involved in this transition are community-based pharmacist practitioners who are primarily involved in leading and advancing team-based patient care services in communities to improve the patient health. This paper will review community-based pharmacy practice innovations and the role of the community-based pharmacist practitioner in the United States.

show abstract

Section: Resultsmentioning

confidence: 99%

Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States

et al. 2019

View full text Add to dashboard Cite

show abstract

“…This proportion was similar to other weight management programs in the community pharmacy. 17 A previous pilot study in Australian community pharmacies showed that 32% of participants achieved a weight loss of 5% after three months of follow-up. 18 In another study, carried out in community pharmacies in the UK, around a quarter of the patients included in the intervention achieved 5% reduction in body weight at 3 months.…”

Section: Discussionmentioning

confidence: 98%

“…According to a previous scoping review, 17 weight management programs carried out in community pharmacies have until now been centered on behavioral counselling given to the patients. However, none of them have included in the intervention the evaluation of other chronic diseases and optimization of medication.…”

Section: Discussionmentioning

confidence: 99%

“…Obesity has reached pandemic levels with more than 1.4 billion adults affected worldwide and its prevalence is increasing. 16 A recent scoping review of research articles 17 showed that community pharmacists have an important role in the prevention and management of overweight and obesity. A pilot study in Australia developed and evaluated a pharmacist-delivered, non-product-centered weight management service for community pharmacies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

<p>Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study</p>

Gómez-Martinez¹,

López-Pintor²,

Lumbreras³

2020

PPA

View full text Add to dashboard Cite

The aim of this study was to evaluate the provision of a professional pharmaceutical patient-centered model in a weight management program and optimization of the medication in a Spanish community pharmacy. Patients and Methods: This was a single-group intervention study with a mean follow-up period of 8.2 months (sd 2.3). Patients ≥18 years old seeking to lose weight or improve eating habits were recruited. On the first visit, the pharmacist collected patients' sociodemographic and anthropometric variables, dietary history and lifestyle habits, biochemical measurements and other clinical and therapeutic data. The intervention was based on the Spanish Society of Community Pharmacy recommendations for diet and exercise and for pharmacotherapy management. The follow-up included a two-month visit and a final visit. Results: A total of 330 patients were included (80% women; mean age 51.3 years old (sd 15.3)). A statistically significant reduction in anthropometric measurements (weight, BMI, and waist circumference) and a statistically significant increase in the number of patients with normal cholesterol and LDL-cholesterol (p<0.001) were observed at two-month visit compared with first visit (p<0.001). The number of patients with normal triglyceride levels at final visit compared with first visit also increased significantly (p=0.04). A total of 186 (56.4%) patients had drugrelated problems at first visit and 31 (9.4%) patients at two-month visit. Conclusion: The implementation of a patient-centered weight management model had a positive impact on the improvement of anthropometric, clinical and therapeutic parameters.

show abstract

“…Seventeen articles were obtained and summarized (Table 1). [14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] In the past 10 years, most of the literature on pharmacy-led obesity management comes from community pharmacy initiatives worldwide (U.S., U.K., Spain, Australia, and Thailand) to implement weight-loss or weight-management programs as a service to the community. Most of the interventions used were pre/post studies to determine the effect of the pharmacist-led service.…”

Section: Clinical Pharmacists' Intervention In the Literaturementioning

confidence: 99%

Clinical review and role of clinical pharmacists in obesity management: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy

Clements

Albanese

D’Souza

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

The objective of this practice and research network opinion paper was to identify literature for pharmacist-led services with obesity management, summarize clinical evidence for this disease state, and describe the role of a clinical pharmacist among patients who are overweight or have obesity. Clinical pharmacists play a critical role in the safe and effective management of obesity in both the inpatient and outpatient settings. In an outpatient setting, the role of the clinical pharmacist includes a comprehensive patient interview to design an individualized therapeutic plan involving nonpharmacological interventions with or without pharmacological interventions or surgical options. A clinical pharmacist conducts a risk-benefit analysis for pharmacological interventions. Furthermore, the potential of medications to contribute to weight gain or prevent weight loss can be reviewed by a clinical pharmacist when managing comorbid conditions. In an inpatient setting, a clinical pharmacist conducts medication reconciliation, determines appropriate supplements for nutritional deficiencies, and provides medication management for people with obesity who may or may not be undergoing bariatric surgery. In addition, a clinical pharmacist can provide thorough patient education with monitoring for transitions from hospital to the outpatient setting and subsequent follow-up visits.

show abstract

Weight management counselling among community pharmacists: a scoping review

Cited by 13 publications

References 36 publications

Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States

Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States

<p>Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study</p>

Clinical review and role of clinical pharmacists in obesity management: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy

Contact Info

Product

Resources

About